Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 92292

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : May | Volume : 16 | Issue : 5 | Page : DC27 - DC31 Full Version

Evaluation of Antimicrobial Potency of Tinospora cordifolia on Subgingival Microbiota: An In-vitro Study


Published: May 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/52118.16380
Yandapalli Roja, C Greeshma, MLV Prabhuji, K Arul Selvam, C Spandana

1. Postgraduate, Department of Periodontology, Krishnadevaraya College of Dental Sciences and Hospital, Bangalore, Karnataka, India. 2. Assistant Professor, Department of Periodontology, M.S Ramaiah Dental College and Hospital, Bangalore, Karnataka, India. 3. Head, Department of Periodontology, Krishnadevaraya College of Dental Sciences and Hospital, Bangalore, Karnataka, India. 4. Head, Department of Microbiology, Krishnadevaraya College of Dental Sciences and Hospital, Bangalore, Karnataka, India. 5. Undergraduate Student, Krishnadevaraya College of Dental Sciences and Hospital, Bangalore, Karnataka, India.

Correspondence Address :
Dr. Yandapalli Roja,
Postgraduate, Department of Periodontology, Krishnadevaraya College of Dental Sciences and Hospital, Hunsamarn Halli, Bangalore-562157, Karnataka, India.
E-mail: rojaroyal246@gmail.com

Abstract

Introduction: Tinospora cordifolia (Tc), a well-known ayurvedic herb commonly known as giloy, has demonstrated multifaceted benefits, such as anti-inflammatory, analgesic, antibacterial and antioxidant properties, in animal, as well as, in-vitro studies. All these are properties which can be collectively applied in the management of periodontal conditions which demonstrate infective as well as inflammatory facets. But prior to its applications as such, it is necessary to definitively determine the optimal concentration and mode of application of the medication.

Aim: To evaluate the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Tc on general subgingival microbiota.

Materials and Methods: The in-vitro, analytical study was conducted in Krishnadevaraya Dental College and Hospital, Bengaluru, Karnataka, India for duration of two and half months starting from November 2021 to January 2022. Ethanolic extracts of Tc were prepared in serial dilutions. Subgingival plaque samples of 12 chronic periodontitis patients were collected, cultured on Brain Heart Infusion (BHI) agar and subject to serial dilutions of Tc. In-vitro antibacterial activity of the ethanolic extracts was assessed using agar well diffusion method with Chlorhexidine (CHX) as positive control and Dimethyl sulfoxide (DMSO) as negative control, MIC and MBC were determined based on the zones of inhibition after 48 hours of anaerobic incubation. The Statistical Package for Social Sciences (SPSS) for windows version 22.0 was used to perform statistical analyses.

Results: The MIC of Tc was noted to be 100 mg/mL where the maximum zone of inhibition was 11.42 mm. MBC was noted at a concentration of 25 mg/mL. The zones of inhibition at these concentrations was comparable to the CHX. The difference in the diameter of the zones produced by Tc, DMSO/Saline and CHX were statistically significant.

Conclusion: Although CHX remains the gold standard, Tc extract has significant antimicrobial activities and can be considered for further clinical trials.

Keywords

Amritha, Antimicrobial efficacy, Chronic periodontitis, Chlorhexidine

Chronic Periodontitis (CP), an inflammatory disease of the supporting tissues of the teeth, results in attachment loss and alveolar bone resorption through host inflammatory response. Although multifactorial, it is primarily driven by the anaerobic bacterial species of the subgingival biofilm, consisting mainly of anaerobic bacterial species (1).

Scientific literature has indicated that certain periodontopathogens such as Aggregatibacter actinomycetemcomitans, Tannerella forsythia and Porphyromonas gingivalis, when present even in very small proportions can affect the integrity of the periodontium (2),(3). Apart from the bacteria themselves, the collective noxious products of plaque also reach the subgingival tissues resulting in inflammatory responses such as increased vascularity and leukocyte diapedesis. The effects of these are compounded by the products of the host immunity, attempting to combat the persistent bacteria challenge. The initial reaction to this is gingivitis which may progress to periodontitis, clinically evidenced by deep periodontal pockets, mobility etc., if left untreated (4).

Complete elimination of plaque microorganisms, is therefore the first step in the treatment of periodontal diseases (1). Comprehensive mechanical therapy, although considered the gold standard in plaque removal, is bound by limitations such as difficulty in accessing certain areas, very deep periodontal pockets, dentinal tubules, root surface irregularities, root concavities, bifurcations, and large invaginations and addressing the tissue invasive microorganisms. The periodontal pocket is one such microniche, wherein the environment is partially sheltered from the physical shear forces in the oral cavity allowing the microorganisms to thrive (5). These are the reasons necessitating adjunctive measures for periodontal therapy like antimicrobial therapy (6), lasers, photodynamic therapy (7),(8) and host modulation (9),(10). The most commonly used of these is antimicrobial therapy, either in systemic or local formulations (11).

But indiscriminate use of antimicrobials in dentistry has led to antimicrobial resistance (12), a global concern, resulting in increased morbidity, mortality, healthcare costs. These adverse effects and high dosage of systemic medication needed to influence the plaque bacteria prompted the research towards alternative sources such as herbal medication (13).

Earlier in 20th century herbal medication such as morphine, aspirin, ergot alkaloids were primarily in use, as synthetic analgesics and antibiotics were not available. But due to the faster therapeutic action of allopathic medication, its counterpart gradually lost ground to the former. Despite this, approximately 70-80% of population still use herbal medication as primary healthcare, as it is deemed to have fewer side effects and to be more compatible with the human body. (WHO 2003) (14). But most of the evidence in support of herbal medication is anecdotal, without much scientific justification or well -designed studies to support or validate their modes of action. This statement holds true in the field of periodontia as well.

A wide range of herbal extracts, Acacia catechu (Cutch tree), Aloe vera, Azadirachta indica (Neem), Glycyrrhiza glabra (Licorice), Ocimum sanctum L (holy basil), Curcuma longa (turmeric), and Matricaria chamomilla (Chamomile), to name a few, have demonstrated potent anti-inflammatory, antibacterial, antioxidant, and astringent properties when used to treat periodontal conditions (15). Some are currently incorporated in popular dentrifices and chemical plaque control aids like Neemayu neemTM tooth paste (Neem extract), HerbodentTM, DantkanthTM (Eucalyptus, lemon, giloy, clove and cinnamon extracts), MeswakTM, Colgate HerbalTM (Myrrh, sage, eucalyptus, tea tree oil and chamomile), Hi Ora mouthwashTM (Betel leaves), Cur Q fresh mouth rinseTM (Mint, tulasi, cloveoil and curcumin) Periowash mouthwashTM (Oregano, Cinnamon and Clove) etc.

The Tc, otherwise known as Guduchi, Amritha, Giloya, is a deciduous climbing shrub reported to possess antimicrobial (16), anti-inflammatory (17), immunosuppressive (18), antiallergic, antidiabetic (19) and antispasmodic properties and to increase antibody production in-vivo in animal studies (20). Despite this, studies regarding this herb in periodontal conditions are few. Since periodontitis is a multifactorial disease, usage of herbal products with multiple effects would be beneficial. No allopathic drug has shown multifaceted actions similar to Tc. Furthermore, the acquisitions of resistance of microorganisms for herbal products are reported to be minimal.

Numerous individual periodontopathogens have been tested against Tc, and its Minimum Inhibitory Concentration (MIC) for the same has been determined, but there are no studies which have assessed its effect against collective subgingival microbiota. This would be more relevant to the application of this herbal medication against periodontitis which is known to be caused by plaque bacteria as a whole. This in-vitro study was the first to determine the MIC as well as MBC of Tc against the aforementioned periodontal pathogens.

Material and Methods

The present study was an in-vitro, analytical study done in Department of Periodontics, Krishnadevaraya College of Dental Sciences and Hospital, Bengaluru, Karnataka, India for two and half months from November 2021 to January 2022. The study was done in accordance to Helsinki declaration, after obtaining the ethical clearance from the Institutional Ethical Board (Ethical clearance no. KCDS/Ethical Comm/SS/02/2020-21). The subjects for this study were selected from the outpatient department of the same, upon meeting inclusion and exclusion criteria. Informed consent was obtained from all the patients for sample collection.

Sample size calculation: A total of 12 patients with chronic periodontitis were selected for the purpose of the study based on sample size analysis done using G Power software v. 3.1.9.4 (Franz Faul, Universität Kiel, Germany), considering the effect size to be measured (dz) at 80% for two-tailed hypothesis, power of the study at 80% and the margin of the error at 5%.

Inclusion criteria: Patients between the ages of 30-50 years, diagnosed with moderate chronic periodontitis, presence of periodontal pockets (5-7 mm), clinical and radiographic evidence of bone loss were selected for the study. They were required to provide the written informed consent.

Exclusion criteria: Non compliant patients, patients who received any surgical or non surgical therapy six months before the start of the study, pregnant or lactating females, use of systemic antibiotics in the past six months and smokers/alcoholics were excluded from the study.

Preparations of Plant Extract (21),(22)

Non destructive cold percolation method was employed using powder of Tc (procured from local ayurvedic store) with ethanol as per the method detailed by Rosenthaler (1930) (Table/Fig 1)a. The crushed powder of Tc was macerated in ethanol (procured from HiMedia Laboratories Pvt. Ltd.) in a ratio of 1:10 solute versus solvent in a 250 mL conical flask. The entire set up was kept on a rotary shaker (Table/Fig 1)b (990 rpm) at room temperature for 24 hours with intermittent shaking. After 24 hours, the mixture was filtered through Whattman No.1 filter paper (Table/Fig 1)c, and the filtrate (Table/Fig 1)d was allowed to evaporate under room temperature (Table/Fig 1)e. The extract settled at the bottom was used for the experiment at varying concentration. The concentrated extracts were dissolved in ethanol and used for further tests. Filtrate was stored in a refrigerator until use.

Procedure for MIC Estimation

Supragingival hand scaling was done in the quadrant with the deepest pocket ensuring not to disturb the subgingival plaque. Subgingival plaque sample of patients was collected with the help of Gracey curette number 2R/2L and 4R/4L (From Hu-Friedy Mfg. Co) (Table/Fig 2)a, without blood or saliva contamination after thorough supragingival hand scaling (Table/Fig 2)a. The collected plaque sample was transferred to thioglycolate broth containing vitamin K and hemin (Procured from HiMedia Laboratories Pvt. Ltd.) without touching the sides of the test tube, and transported to the laboratory within an hour for microbiological analysis. The plaque samples were vortexed for 10 seconds (Table/Fig 2)b. A 20 μL/mL of the plaque sample was seeded on to the BHI agar with the help of the L spreader (Procured from HiMedia Laboratories Pvt. Ltd.).

(Table/Fig 2)c 6 mm diameter wells were cut on the BHI agar and subjected to three serial doubling dilutions of Tc extract ranging from concentration of 100 mg/mL, 50 mg/mL and 25 mg/mL and taking chlorhexidine (procured from Icpa Health Products Ltd ) as positive control and Dimethyl sulfoxide (DMSO) (procured from Sigma -Aldrich®) as negative control (Table/Fig 2)d (14).

Procedure for MBC Estimation

The 10 different serial doubling dilutions of the Tc extract ranging from 100 mg/mL, 50 mg/mL, 25 mg/mL, 12.5 mg/mL, 6.25 mg/mL, 3.125 mg/mL, 1.625 mg/mL, 0.862 mg/mL, 0.413 mg/mL and 0.206 mg/mL (Table/Fig 2)e were prepared and incubated for two hours in the incubator at 37°C. Then they were streaked on to the brain heart infusion agar plates, with the L spreader, uniformly over the surface of the agar and incubated it at 37°C under strictly anaerobic conditions for 48 hours using anaerobic gas jar and gas pack for anaerobic obligate and facultative bacteria. The colonies were counted using digital colony counter.

Statistical Analysis

Statistical Package for Social Sciences (SPSS) for windows version 22.0 released 2013. Armonk, NY: IBM Corp was used to perform statistical analyses. Descriptive analysis of all the explanatory and outcome parameters were done using frequency and proportions for categorical variables, whereas in Mean and SD for continuous variables. Chi-square test was used to compare the presence of MBC values between 25 mg/mL and 12.5 mg/mL concentrations. One-way ANOVA (Analysis of variance) followed by Tukey’s post hoc analysis was used to compare the mean MIC values between different groups. The level of significance was set at p<0.05.

Results

The values obtained for the microbiological parameters of the 12 patients enrolled in the study were as follows. A total of seven males and five females were included in the study with 30-40 years aged patients significantly higher in number than other two groups. These demographic details are presented in (Table/Fig 3). A total of three different concentrations of Tc extract along with positive and negative control were assessed for antimicrobial activity against the whole subgingival microorganisms. The MIC was assessed based on the zones of the inhibition produced by different concentrations of Tc on BHI agar plates. Simultaneously CHX and DMSO were used as positive and negative controls respectively. At 100 mg/mL concentration, the maximum zone of inhibition noted was 11.42 mm, whereas 50 mg/mL concentration showed 10.92±0.79 and 25 mg/mL concentration demonstrated 10.33 mm. Dilutions lesser than 25 mg/mL failed to produce a significant zone of inhibition and no inhibition zone was observed with negative control (Table/Fig 4). The results with 0.2% CHX, which was used as positive control, showed a maximum zone of inhibition of 16.58±1.17 mm. The difference between the zones of inhibition at 100 mg/mL and 50 mg/mL was not statistically significant, whereas statistical significance was noted between 100 mg/mL and 25 mg/mL. The difference in the diameter of the zones produced by Tc, saline and CHX were statistically significant. 50 mg/mL was as effective as 100 mg/mL (Table/Fig 5),(Table/Fig 6),(Table/Fig 7)a and (Table/Fig 8).

The MBC was determined to assess the least concentration at which no bacterial growth is noted. The MBC of CHX showed absolute no growth (Table/Fig 7)b followed by 100 mg/mL (Table/Fig 7)c and 50 mg/mL (Table/Fig 7)d. The test results showed that the MBC was seen in 75% of the samples at 25 mg/mL (Table/Fig 7)e as compared to 25% of the samples at 12.5 mg/mL (Table/Fig 7)f. This difference in the MBC exhibited by the samples at two different concentrations was statistically significant at p=0.01. This gives the interpretation that concentrations less than 12.5 mg/mL, 6.25 mg/mL (Table/Fig 7)g and negative control, showed (Table/Fig 7)h no demonstrable effect on subgingival microbiota.

Discussion

Anti-infective therapy in the management of periodontitis is not a novel concept but has seen significantly varied drugs being put to use. Most research articles predominantly feature allopathic drugs such as amoxicillin, ciprofloxacin, tetracycline and metronidazole to name a few as stand alone or in combination with each other. Significant adverse effects and antimicrobial resistance have been reported over the years. This has switched the focus towards herbal medication.

Studies on the antibacterial activity of medicinal plants against the microbial ecosystem of the oral cavity and often the cause of periodontal infections are fewer in comparison (22),(23). Due to the difficulty in isolation and identification of the complex microbiota of the oral cavity, in addition to the challenges of standardising techniques to evaluate the antibacterial efficacy of drugs, research articles regarding such medications are less common (24).

Presently multidrug resistance in microbial pathogens have become a serious health hazard to humans worldwide, owing to the indiscriminate, repetitive and at times unethical, use of antimicrobial drugs. There is an urgent need to develop new antimicrobials, which will overcome this as well as the other concerns posed by the existing drugs (8).

This vast, natural, time-tested medicinal resource is worth exploring as a possibility of developing efficient, economically viable, and clinically acceptable antimicrobials. It only remains to be harnessed in the right formulation, which is what has been attempted via this in-vitro study.

Scientifically, plants such as Ocimum sanctum (Tulsi) and Stevia rebaudiana (candy leaf) etc., have proven to be efficacious antimicrobials. Tc, a common tropical shrub, has shown anti-inflammatory (25),(26),(27), analgesic, antibacterial activity (28), antioxidant properties (29), and increase in antibody production in-vivo and immunosuppressive actions in animal studies (30),(31).

In the present investigation ethanolic extracts of the different concentrations of Tc were evaluated to determine the one demonstrating optimal antimicrobial activity. Previous studies have applied the same study design for individual organisms (7),(13),(32) but present study was the first to assess its efficacy against the entire subgingival microbiota of the oral cavity.

In the present study, out of three different concentrations and dilutions tested against the whole subgingival microbiota, maximum inhibition zone of 11.42 mm was found with 100 mg/mL concentration of the extract, 50 mg/mL showing an insignificantly smaller inhibition zone of 10.92 mm, progressively smaller concentrations shown a proportionately smaller inhibition zones. MBC is the lowest concentration of an antibacterial agent required to kill the bacterium. The determination of the MBC of the ethanolic extract of Tc was found at 25 mg/mL for 75% of cases and for 25% of cases it was at 12.5 mg/mL.

The results of this study have given useful information about the inhibiting activity of medicinal plant extracts against periodontal pathogens. In fact, there is no information in the literature on the antibacterial properties of Tc against the subgingival pathogens responsible for periodontopathies.

The results of this study suggest that the use of the ethanolic extracts of Tc as topical medication in periodontal prophylactics or in the alteration of the microbic ecosystem, as mouthwashes or gels based wholly or partially on these plant extracts could be a valid aid to obtain a significant reduction of the total microbial population and, in particular, the most virulent microorganisms.

Limitation(s)

Small sample size and microbiological analysis is both time consuming and expensive.

Conclusion

The CHX showed maximum antibacterial activity against subgingival microbiota than Tc. The use of herbal alternatives in the treatment of chronic periodontitis might prove to be advantageous considering the undesirable characteristics of CHX. Current study aims to highlight the medicinal use of a new herbal product Tc which has shown to possess antimicrobial properties. The results of the study showed that the Tc could effectively inhibit the bacteria found in the subgingival plaque, combating the periodonto-pathogens and it further showed high efficacy in inhibiting the anaerobic bacteria. Hence, it can be used as a successful alternative to synthetic antimicrobials. The dosage and safety of Tc must be considered before it’s possible in-vivo application for successful non surgical therapeutic modality of the management of chronic periodontitis.

References

1.
Caton JG, Armitage G, Berglundh T, Chapple IL, Jepsen S, Kornman KS, et al. A new classification scheme for periodontal and peri-implant diseases and conditions-Introduction and key changes from the 1999 classification. Journal of periodontology. 2018;89(Suppl 1):S1-S8. [crossref] [PubMed]
2.
Popova C, Dosseva-Panova V, Panov V. Microbiology of Periodontal Diseases. Biotechnology & Biotechnological Equipment. 2013;27(3):3754-59. [crossref]
3.
da Silva-Boghossian CM, do Souto RM, Luiz RR, Colombo AP. Association of red complex, A. actinomycetemcomitans and non-oral bacteria with periodontal diseases. Arch Oral Biol. 2011;56(9):899-906. [crossref] [PubMed]
4.
Khosla A, Gupta SJ, Jain A, Shetty DC, Sharma N. Evaluation and comparison of the antimicrobial activity of royal jelly-A holistic healer against periodontopathic bacteria: An in vitro study. Journal of Indian Society of Periodontology. 2020;24(3):221.
5.
Colombo AP, Teles RP, Torres MC, Rosalém W, Mendes MC, Souto RM, et al. Effects of non-surgical mechanical therapy on the subgingival microbiota of Brazilians with untreated chronic periodontitis: 9-month results. Journal of periodontology. 2005;76(5):778-84. [crossref] [PubMed]
6.
Hung HC, Douglass CW. Meta analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss. Journal of clinical periodontology. 2002;29(11):975-86. [crossref] [PubMed]
7.
Azaripour A, Dittrich S, Van Noorden CJ, Willershausen B. Efficacy of photodynamic therapy as adjunct treatment of chronic periodontitis: A systematic review and meta-analysis. Lasers in medical science. 2018;33(2):407-23. [crossref] [PubMed]
8.
Oktawati S, Rukmana A, Patimah, Wahab RF, Syafar IF, Wahab W. Photodynamic Therapy as Adjunctive Treatment of Chronic Periodontitis: A Systematic Review. Systematic Reviews in Pharmacy. 2020;11(6):492-98.
9.
Preshaw PM. Host modulation therapy with anti-inflammatory agents. Periodontology 2000. 2018;76(1):131-49. [crossref] [PubMed]
10.
Hajishengallis G, Chavakis T, Lambris JD. Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy. Periodontology 2000. 2020;84(1):14-34. [crossref] [PubMed]
11.
Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontology 2000. 2016;71(1):82-112. [crossref] [PubMed]
12.
Ardila CM, Granada MI, Guzmán IC. Antibiotic resistance of subgingival species in chronic periodontitis patients. Journal of periodontal research. 2010;45(4):557-63. [crossref] [PubMed]
13.
Bhatia M, Urolagin SS, Pentyala KB, Urolagin SB, KB M, Bhoi S. Novel therapeutic approach for the treatment of periodontitis by curcumin. Journal of clinical and diagnostic research: JCDR. 2014;8(12):ZC65. [crossref] [PubMed]
14.
World Health Organization. Traditional medicine in asia. WHO Regional Office for South-East Asia; 2002.
15.
Sharma A, Batra A. In vivo antimicrobial activity of Indian medicinal plant Tinoscordifolia using serial tube dilution technique. Asian Journal of Pharmaceutical Research and Development. 2013;1(2):148-56.
16.
Singh S, Singh P. Effectiveness of Tinospora cardifolia stem extract on bacteria Salmonella typhi, Pseudomonas aeruginosa, Staphylococcus aureus and Shigella dysenteriae. International Journal of Pharmacy & Life Sciences. 2012;3(8):1923-25.
17.
Pendse VK, Dadhich AP, Mathur PN, Bal MS, Madan BR. Antiinflammatory, immunosuppressive and some related pharmacological actions of the water extract of Neem Giloe (Tinospora cordifolia): A preliminary report. Indian journal of pharmacology. 1977;9(3):221-24.
18.
Prince PS, Menon VP. Antioxidant activity of Tinospora cordifolia roots in experimental diabetes. Journal of ethnopharmacology. 1999;65(3):277-81. [crossref]
19.
Ranjith MS, Ranjitsingh AJ, Shankar SG, Vijayalaksmi GS, Deepa K, Sidhu HS. Enhanced Phagocytosis and Antibody Production by Tinospora cordifolia-A new dimension in Immunomodulation. African Journal of Biotechnology. 2008;7(2):81-85.
20.
Devi M, Sharma A, Navdeep, Saroea S, Kohli M, Bhatt AK. In vitro study of antimicrobial activity of Tinospora cordifolia (Thunb.) Miers plant extracts against selected clinical isolates. Annals of Phytomedicine. 2018;7(2):76-80. [crossref]
21.
Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE. Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study. Toxicology and industrial health. 2016;32(2):246-50. [crossref] [PubMed]
22.
Rosenthaler L. The chemical investigation of plants. F. L. Pvman. 1930;50(18):356. Doi: doi:10.1002/jctb.5000501802. [crossref]
23.
Mishra S, Johnson L, Sangha KS, Gupta V, Agarwal S, Rajput S. An in vitro study to determine the physicochemical, mechanical, and antibacterial properties of a novel spirulina containing controlled release intrapocket drug delivery system. Journal of Pharmacy & Bioallied Sciences. 2021;13(2):178-87.
24.
Dib K, Ennibi O, Alaoui K, Cherrah Y, Filali-Maltouf A. Antibacterial activity of plant extracts against periodontal pathogens: A systematic review. Journal of Herbal Medicine. 2021. Doi: https://doi.org/10.1016/j.hermed.2021.100493. [crossref]
25.
Philip S, Tom G, Vasumathi AV. Evaluation of the anti-inflammatory activity of Tinospora cordifolia (Willd.) Miers chloroform extract-a preclinical study. The Journal of Pharmacy and Pharmacology. 2018;70(8):1113-25. [crossref] [PubMed]
26.
Birla H, Rai SN, Singh SS, Zahra W, Rawat A, Tiwari N, et al. Tinospora cordifolia suppresses neuroinflammation in parkinsonian mouse model. Neuromolecular medicine. 2019;21(1):42-53. [crossref] [PubMed]
27.
Jacob J, Prakash BK. Dihydroxy berberine from Tinospora cordifolia: In silico evidences for the mechanism of anti-inflammatory action through dual inhibition of Lipoxygenase and Cyclooxygenase. Indian Journal of Biochemistry and Biophysics (IJBB). 2021;58(3):244-52.
28.
Bhardwaj A, Srivastava N, Rana V, Adlakha VK, Asthana AK. How efficacious are Neem, Tulsi, Guduchi extracts and chlorhexidine as intracanal disinfectants? A comparative ex vivo study. Ayu. 2017;38(1-2):70-75. [crossref] [PubMed]
29.
Sharma R, Bolleddu R, Maji JK, Ruknuddin G, Prajapati PK. In-vitro ??-amylase, ??-glucosidase inhibitory activities and in-vivo anti-hyperglycemic potential of different dosage forms of Guduchi (Tinospora cordifolia [Willd.] Miers) prepared with Ayurvedic Bhavana process. Frontiers in Pharmacology. 2021;12:642300. [crossref] [PubMed]
30.
Devi P. A review on Tinospora cordifolia: As an Immunomodulating agent. Himalayan Journal of Health Sciences. 2021;6(1):06-14. [crossref]
31.
Panchabhai TS, Kulkarni UP, Rege NN. Validation of therapeutic claims of Tinospora cordifolia: A review. Phytother Res. 2008;22(4):425-41. Doi: 10.1002/ptr.2347. [crossref] [PubMed]
32.
Vermani A, Navneet, Gautam SS. Screening of antibacterial activity of Tinospora cordifolia Miers extracts against dental pathogens. J Pharmacol Toxicol. 2013;8(1):28-34. [crossref]

DOI and Others

DOI: 10.7860/JCDR/2022/52118.16380

Date of Submission: Aug 26, 2021
Date of Peer Review: Nov 15, 2021
Date of Acceptance: Mar 02, 2022
Date of Publishing: May 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: Funded from Rajiv Gandhi University of Health Sciences (RGUHS)
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Aug 27, 2021
• Manual Googling: Feb 09, 2022
• iThenticate Software: Apr 04, 2022 (19%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com